BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hüsing A, Kabar I, Schmidt HH. Lipids in liver transplant recipients. World J Gastroenterol 2016; 22(12): 3315-3324 [PMID: 27022213 DOI: 10.3748/wjg.v22.i12.3315]
URL: https://www.wjgnet.com/1007-9327/full/v22/i12/3315.htm
Number Citing Articles
1
Nima Mehdizadegan, Seyed Mohsen Dehghani, Roya Najafi, Masoud Tahani, Iraj Shahramian. Comparison of Lipid Profiles Between Pediatric Living- and Deceased-Donor Liver RecipientsJournal of Comprehensive Pediatrics 2024; 15(2) doi: 10.5812/jcp-142461
2
Dongni Lin, Yefeng Lu, Bijun Qiu, Mingxuan Feng, Yi Luo, Feng Xue, Tao Zhou, Jianjun Zhu, Jianjun Zhang, Lvya Wang, Qiang Xia, Ping Wan. The therapeutic effect of liver transplantation in 14 children with homozygous familial hypercholesterolemia: a prospective cohortJournal of Clinical Lipidology 2024;  doi: 10.1016/j.jacl.2024.08.008
3
Pavel Kraml. Lipid-lowering therapy in selected specific groups of patientsMedicína pro praxi 2020; 17(3): 151 doi: 10.36290/med.2020.029
4
Bruce A. Warden, P. Barton Duell. Management of dyslipidemia in adult solid organ transplant recipientsJournal of Clinical Lipidology 2019; 13(2): 231 doi: 10.1016/j.jacl.2019.01.011
5
Dan Tu, Yihan Zhang, Xiao Liu, Yan Xu, Huixin Chen, Ziqing Hei, Shuhong Yi, Mian Ge. Functional analysis of hepatic long non‐coding ribonucleic acids during liver transplantation in humansThe Journal of Gene Medicine 2023; 25(7) doi: 10.1002/jgm.3502
6
Maria Corina Plaz, Emmanuel A. Tsochatzis. Textbook of Liver Transplantation2022; : 357 doi: 10.1007/978-3-030-82930-8_20
7
Rong-Li Wei, Guang-Han Fan, Chen-Zhi Zhang, Kang-Chen Chen, Wen-Hui Zhang, Chang-Biao Li, Si-Yi Dong, Jun-Li Chen, Sun-Bin Ling, Shu-Sen Zheng, Xiao Xu. Prognostic implication of early posttransplant hypercholesterolemia in liver transplantation for patients with hepatocellular carcinomaHepatobiliary & Pancreatic Diseases International 2023; 22(3): 228 doi: 10.1016/j.hbpd.2022.05.005
8
A. O. Bueverov, P. O. Bogomolov, A. A. Kucherov, V. E. Syutkin. Alirokumab in the practice of a multidisciplinary outpatient hospital: results of an open, noncomparative prospective studySechenov Medical Journal 2021; 11(4): 15 doi: 10.47093/2218-7332.2020.11.4.15-22
9
A. A. Kucherov, A. I. Ershova, V. E. Syutkin, O. M. Drapkina. Features of lipid-lowering therapy in liver transplant recipientsCardiovascular Therapy and Prevention 2024; 22(12): 3872 doi: 10.15829/1728-8800-2023-3872
10
Branislav Kollar, Pranitha Kamat, Holger J. Klein, Matthias Waldner, Riccardo Schweizer, Jan A. Plock. The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite AllotransplantationJournal of Vascular Research 2019; 56(4): 163 doi: 10.1159/000500958
11
S. E. Voskanyan, V. E. Syutkin, A. I. Sushkov, Yu. V. Voskanyan, A. Yu. Veselkova, А. S. Luk'yanchikova, A. A. Kucherov. Extrahepatic causes of morbidity and mortality of liver recipients in the long-term posttransplantation periodBulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH) 2023; 13(4): 134 doi: 10.20340/vmi-rvz.2023.4.TX.1
12
Èlia Pérez-Amate, Marta Roqué-Figuls, Miguel Fernández-González, Maria Giné-Garriga. Exercise interventions for adults after liver transplantationCochrane Database of Systematic Reviews 2023; 2023(5) doi: 10.1002/14651858.CD013204.pub2
13
Amit D. Kandhare, Debasish Bandyopadhyay, Prasad A. Thakurdesai. Low molecular weight galactomannans-based standardized fenugreek seed extract ameliorates high-fat diet-induced obesity in miceviamodulation of FASn, IL-6, leptin, and TRIP-Br2RSC Advances 2018; 8(57): 32401 doi: 10.1039/C8RA05204B
14
Hai-Tao Huang, Xue-You Zhang, Cheng Zhang, Qi Ling, Shu-Sen Zheng. Predicting dyslipidemia after liver transplantation: A significant role of recipient metabolic inflammation profileWorld Journal of Gastroenterology 2020; 26(19): 2373 doi: 10.3748/wjg.v26.i19.2373
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
15
Hai-Tao Huang, Xue-You Zhang, Cheng Zhang, Qi Ling, Shu-Sen Zheng. Predicting dyslipidemia after liver transplantation: A significant role of recipient metabolic inflammation profileWorld Journal of Gastroenterology 2020; 26(19): 2374-2387 doi: 10.3748/wjg.v26.i19.2374
16
Chenzhi Zhang, Kangchen Chen, Rongli Wei, Guanghan Fan, Xuechun Cai, Li Xu, Beini Cen, Jianguo Wang, Haiyang Xie, Shusen Zheng, Xiao Xu. The circFASN/miR-33a pathway participates in tacrolimus-induced dysregulation of hepatic triglyceride homeostasisSignal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-0105-2
17
Maaike Kockx, Leonard Kritharides. Hyperlipidaemia in immunosuppressionCurrent Opinion in Lipidology 2016; 27(6): 631 doi: 10.1097/MOL.0000000000000363
18
Nathan G. Kim, Avneesh Sharma, Sammy Saab. Cardiovascular and metabolic disease in the liver transplant recipientBest Practice & Research Clinical Gastroenterology 2020; : 101683 doi: 10.1016/j.bpg.2020.101683
19
Èlia Pérez-Amate, Marta Roqué i Figuls, Miguel Fernández-González, Maria Giné-Garriga. Exercise interventions for adults after liver transplantationCochrane Database of Systematic Reviews 2018;  doi: 10.1002/14651858.CD013204
20
Anchalia Chandrakumaran, Mohammad Shadab Siddiqui. Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver TransplantGastroenterology Clinics of North America 2020; 49(1): 165 doi: 10.1016/j.gtc.2019.09.005
21
Haitang Qiu, Shajidan Abudureyimu, Mengjia Liu, Fen Liu, Ying Gao. Study on the Interaction Between C3 Gene Polymorphism and Environment in Patients with Type 2 Diabetes Combined with Coronary Artery DiseaseDiabetes, Metabolic Syndrome and Obesity 2024; : 1467 doi: 10.2147/DMSO.S447789
22
Oana Plotogea, Madalina Ilie, Vasile Sandru, Alexandru Chiotoroiu, Ovidiu Bratu, Camelia Diaconu. Cardiovascular and Metabolic Consequences of Liver Transplantation: A ReviewMedicina 2019; 55(8): 489 doi: 10.3390/medicina55080489
23
Jon A. Kobashigawa, Bengt FellstrÖm, Patrick B. Mark, Alan G. Jardine. Clinical Lipidology2024; : 358 doi: 10.1016/B978-0-323-88286-6.00037-6
24
Nicholas Hoppmann, Omar Massoud. Medical care of liver transplant patientsExpert Review of Gastroenterology & Hepatology 2020; 14(10): 901 doi: 10.1080/17474124.2020.1797483
25
Peggy E Miller, Paula McQuail, Charlotte F Doran, Kevin McSorley, Paul Curtin. A Case of Multi-focal Osteonecrosis in the Context of Liver Transplant Following Ingestion of Amanita phalloides Mushroom ToxinCureus 2021;  doi: 10.7759/cureus.19513
26
Mikko Karpale, Janne Hukkanen, Jukka Hakkola. Nuclear Receptor PXR in Drug-Induced HypercholesterolemiaCells 2022; 11(3): 313 doi: 10.3390/cells11030313
27
Filippo Gabrielli, Lucia Golfieri, Fabio Nascimbeni, Pietro Andreone, Stefano Gitto. Metabolic Disorders in Liver Transplant Recipients: The State of the ArtJournal of Clinical Medicine 2024; 13(4): 1014 doi: 10.3390/jcm13041014
28
Maaike Kockx, Leonard Kritharides. The Molecular Nutrition of Fats2019; : 323 doi: 10.1016/B978-0-12-811297-7.00025-1
29
Li-Jian Chen, Yang Xin, Miao-Xian Yuan, Chun-Yi Ji, Yu-Ming Peng, Qiang Yin. CircFOXN2 alleviates glucocorticoid- and tacrolimus-induced dyslipidemia by reducing FASN mRNA stability by binding to PTBP1 during liver transplantationAmerican Journal of Physiology-Cell Physiology 2023; 325(3): C796 doi: 10.1152/ajpcell.00462.2022
30
Gianluigi Cuomo, Giuseppe Cioffi, Anna Di Lorenzo, Francesca Paola Iannone, Giuseppe Cudemo, Anna Maria Iannicelli, Mario Pacileo, Antonello D’Andrea, Carlo Vigorito, Gabriella Iannuzzo, Francesco Giallauria. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Use for Atherogenic Dyslipidemia in Solid Organ Transplant PatientsJournal of Clinical Medicine 2022; 11(11): 3247 doi: 10.3390/jcm11113247
31
Gabriella Iannuzzo, Gianluigi Cuomo, Anna Di Lorenzo, Maria Tripaldella, Vania Mallardo, Paola Iaccarino Idelson, Caterina Sagnelli, Antonello Sica, Massimiliano Creta, Javier Baltar, Felice Crocetto, Alessandro Bresciani, Marco Gentile, Armando Calogero, Francesco Giallauria. Dyslipidemia in Transplant Patients: Which Therapy?Journal of Clinical Medicine 2022; 11(14): 4080 doi: 10.3390/jcm11144080
32
Romelia Barba Bernal, Esli Medina-Morales, Daniela Goyes, Vilas Patwardhan, Alan Bonder. Management of Autoimmune Liver Diseases after Liver TransplantationTransplantology 2021; 2(2): 162 doi: 10.3390/transplantology2020016
33
Yeung Jek Ho, Audrey Su-Min Koh, Zhi Hao Ong, Cheng Han Ng, Gwyneth Kong, Nicholas W.S. Chew, Hui Ning Lim, M. Shadab Siddiqui, Mark Dhinesh Muthiah. The Underutilization, Adverse Reactions and Efficacy of Statins after Liver Transplant: A Meta-Analysis and Systematic ReviewTransplantology 2021; 2(3): 264 doi: 10.3390/transplantology2030025
34
Cornelius Engelmann, Niklas F. Aehling, Stefan Schob, Ines Nonnenmacher, Luise Handmann, Jane Macnaughtan, Adam Herber, Alexey Surov, Thorsten Kaiser, Timm Denecke, Rajiv Jalan, Daniel Seehofer, Michael Moche, Thomas Berg. Body fat composition determines outcomes before and after liver transplantation in patients with cirrhosisHepatology Communications 2022; 6(8): 2198 doi: 10.1002/hep4.1946
35
Mohammed Al Dubayee, Meral Kayikcioglu, Jeanine Roeters van Lennep, Nadia Hergli, Pedro Mata. Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global CasesAdvances in Therapy 2022; 39(6): 3042 doi: 10.1007/s12325-022-02131-3